TVTX   $18.25  2.18% Market Closed After Close 18.4 0.82%

Travere Therapeutics Inc
Total Cash 277.44M
totalCashPerShare 3.555
EBITDA -238.74M
Total Debt 402.43M
quickRatio 1.606
currentRatio 1.709
Total Revenue 203.45M
debtToEquity
Revenue/Share 2.634
ROA -0.26143998
ROE -2.79937
grossProfits
freeCashflow -214.69M
operatingCashflow -272.23M
earningsGrowth
revenueGrowth 0.696
grossMargins -0.10560001
ebitdaMargins -1.17346
operatingMargins -0.89074
profitMargins -1.7275
enterpriseValue 1.51B
forwardPE -13.410852
floatShares 57.87M
sharesOutstanding 78.05M
sharesShort 8.11M
sharesShortPriorMonth 8.66M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.14%
Short Ratio help_outline 3.02%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue -0.391
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -348.96M
trailingEps -4.52%
forwardEps -1.29%
enterpriseToEbitda -6.33
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.61 4Q 2024
institutionsCount 248
lastUpdated Nov. 7, 2024, 3:29 a.m.